Xeris Biopharma Holdings XERS
NASDAQ XERS
$9.56 -0.42 (-4.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

Xeris Biopharma Holdings (XERS) EV to EBITDA (2025 - 2026)

Updated

Xeris Biopharma Holdings' EV to EBITDA came in at 25.69 for Q2 2026, down 91.6% from 304.09 a year earlier but up 39.0% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) EV to EBITDA (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Xeris Biopharma Holdings reported EV to EBITDA of 19.25, down 91.1% year-over-year; for FY2025, it came in at 32.22.

  • The five-year range for quarterly EV to EBITDA is 18.49 (Q1 2026) to 304.09 (Q2 2025).
  • Business Quant data shows XERS's EV to EBITDA at 18.49 (Q1 2026), 32.22 (Q4 2025) and 57.25 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Xeris Biopharma Holdings 1.73 Bn 1.30 Bn 79.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.69
Mar 31, 2026 18.49
Dec 31, 2025 32.22
Sep 30, 2025 57.25
Jun 30, 2025 304.09
API Access

Xeris Biopharma Holdings EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=XERS&period=max&api_key=YOUR_API_KEY